CAMI MORELL, JORDI

Departament de Ciències Experimentals i de la Salut
Ciènc.Experiment.i de la Salut (Grup de Recerca)

+34 933160016
[email protected]
Dr. Aiguader, 88 08003 Barcelona

OORCID LinkORCID


Personal profile in our Scientific Output Portal (PPC)  

MD, PhD, Professor of Pharmacology (specialist in Clinical Pharmacology) at Pompeu Fabra University in Barcelona (UPF) General Director of the Barcelona Biomedical Research Park (PRBB) and Vice-President of Pasqual Maragall Foundation for Alzheimer's Research.

Short biographical sketch

Jordi Camí, (Terrassa, 1952) received his Degree in Medicine in 1975 and his PhD in 1977. He is Professor of Pharmacology, General Director of the Barcelona Biomedical Research Park (PRBB), and Vice-President of the Pasqual Maragall Foundation. His scientific activity has been focused on the field of Neurosciences (drug dependence, cognition), having explored other fields such as Bibliometry, Evaluation and Scientific Policy. His academic activity has been carried out between the Autonomous University of Barcelona (UAB) and the Pompeu Fabra University (UPF), having held the positions of Delegate of the Rector, Dean and Director of the department. Member of the Institute for Catalan Studies (Institut d’Estudis Catalans – IEC. He has been, among others, member of the Advisory Council of the Ministry of Health and the Bioethics Committee of Spain. He is currently the President of CIR-CAT (Committee for the Integrity of Research in Catalonia).

 

Research lines

Neuroscience behind magic

https://virtualmindlab.org/

 

Publications

Selected publications in the last 5 years (2015-2020):

 

1. Gómez-Marín A, Martínez LM, Camí J. Science as magic. Organisms, Journal of Biological Sciences 2020 (in press) 

2. Bestué D, Martínez LM, Gómez-Marín A, Gea MA, Camí J. Long-term memory of real-world episodes is independent of recency effects: Magic tricks as ecological tasks. PsyArXiv 2020. Available at https://psyarxiv.com/np4t5

3. Camí J, Gómez-Marín A, Martínez LM. On the cognitive bases of illusionism: An untapped tool for brain and behavioral research. Preprints 2020. 2020010011 (doi: 10.20944/preprints202001.0011.v1)

4. Camí J, Martínez LM. El cerebro ilusionista: La neurociencia detrás de la magia. Barcelona: RBA Libros; 2020.

5. Zaghi-Lara R, Gea MA, Camí J, Martínez LM, Gómez-Marín A. Playing magic tricks to deep neural networks untangles human deception. 2019. Available at: https://arxiv.org/abs/1908.07446.

6. Rojas S, Brugulat-Serrat A, Bargalló N, Minguillón C, Tucholka A, Falcon C, Carvalho A, Morán S, Esteller M, Gramunt N, Fauria K, Camí J, Molinuevo JL, Gispert JD. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study. J Cereb Blood Flow Metab 2018; Feb;38(2):250-61.

7. Molinuevo JL, Camí J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish J. Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimers Dement 2016; May;12(5):614-22. 

8. Molinuevo JL, Gramunt N, Gispert JD, Fauria K, Esteller M, Minguillon C, Sánchez-Benavides G, Huesa G, Morán S, Dal-Ré R, Camí J. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 2016; 2(2): p. 82-92. 

9. Farré M, Tomillero A, Pérez-Mañá C, Yubero S, Papaseit E, Roset PN, Pujadas M, Torrens M, Camí J, de la Torre R. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart. Eur Neuropsychopharmacol 2015; 25(10):1637 - 49.